UX143(cetrusumab)

搜索文档
Ultragenyx Pharmaceutical(RARE) - 2025 Q2 - Earnings Call Transcript
2025-08-06 06:02
Ultragenyx Pharmaceutical (RARE) Q2 2025 Earnings Call August 05, 2025 05:00 PM ET Company ParticipantsJoshua Higa - VP - IREmil Kakkis - Founder, President & CEOErik Harris - EVP & CCOHoward Horn - CFO & EVP - Corporate StrategyEric Crombez - EVP & Chief Medical OfficerWill Soghikian - VP - Equity ResearchGena Wang - MD - Biotech Equity ResearchTazeen Ahmad - MD - US Equity ResearchYigal Nochomovitz - DirectorTommie Reerink - Biotech Equity Research AssociateMaxwell Skor - VP - Biotech Equity ResearchHanna ...